Gynecologic and Obstetric Pathology
- Continuing Education
Explore the latest clinically relevant updates in gynecologic and obstetric pathology, with expert-led guidance on evolving classifications, diagnostic criteria, staging, and practice guidelines. Apply current knowledge through interactive lectures and real-world slide sessions focused on challenging diagnoses, differential diagnoses, and practical approaches for practicing pathologists.
- Live Online
This course is taught online in real time.
Additionally, all sessions will be recorded and made available to participants for on-demand online viewing for 90 days after the end of the course.
$700
For a full list of profession pricing see below.
View All
Continuing Education
Earn up to:
22.75 AMA PRA Category 1 Credits™.
View All
All evaluations and credit claims must be completed within 60 days of the course end date.
3 Days
Please view the Schedule for a full description of the program.
On This Page
Overview
This inaugural course provides timely, clinically relevant and contemporary updates in the practice of Gynecologic and Obstetric Pathology. The course is organized and delivered by nationally and internationally renowned experts in gynecologic and obstetric pathology at Mass General Brigham.
Emphasis is given to important shifts in pathology definitions, classification, diagnostic criteria, and staging of gynecologic and obstetric conditions, reflecting recommendations by the World Health Organization Classification, the American Joint Committee on Cancer and International Federation of Obstetrics and Gynecology staging systems, and practice guidelines (such as the College of American Pathologists, International Collaboration on Cancer Reporting, the National Comprehensive Cancer Network, and the European Society of Gynecologic Oncology). Critical updates in each organ system and disease category are organized in dedicated lectures, focusing on practical guidance and rules for general practicing pathologists. About half of the course content is dedicated to slide sessions, in which illustrative examples of critical diagnostic entities and their differential diagnoses are discussed by the experts, mirroring a real-practice sign-out setting. Emerging and diagnostically challenging entities are covered in detail. Both lectures and slide sessions are designed to be interactive and promote participation by the audience.
Learning Objectives
- Understand and apply in daily practice essential resources, including the upcoming WHO classification of tumors of the female reproductive system, the Amsterdam consensus guideline on placental pathology, the most recent updates to the FIGO staging systems, ICCR resources, and current NCCN guidelines for the management of patients with gynecologic cancer.
- Identify the scenarios in which diagnosis of non-epithelial (mesenchymal, sex-cord stromal, gestational) gynecologic neoplasia, as per WHO criteria, requires molecular testing as an essential criterion, and how to proceed when such testing is not available.
- Identify the most common pathologic lesions found in the placenta, understanding their relevance in terms of correlation with adverse maternal and fetal outcomes, recurrence in future gestations and need for immediate / prompt intervention.
- Discuss the role of biomarker testing in the diagnosis, prognosis and management of patients with ovarian cancer, endometrial cancer, and cervical cancer.
- Appraise emerging information on clinically relevant forms of endometrial, upper genital and mesenchymal gynecologic neoplasia.
- Describe the novel classification systems for lower genital tract neoplasia including the currently recommended nomenclature.
- Recognize forms of gestational trophoblastic neoplasia applying strict diagnostic criteria and judicious use of ancillary testing.
Developed and Offered By:
Continuing Education courses are developed by faculty from Harvard Medical School's teaching hospitals and accredited by Harvard Medical School. This course is offered by Massachusetts General Brigham.
Schedule
All agenda sessions are in Eastern Time.
Monday, April 12, 2027
Welcome and Introduction
8:00-8:15 am
Pre-invasive and invasive vulvar squamous neoplasia
8:15-9:00 am
Crucial differential diagnoses in vulvovaginal biopsies
9:00-10:00 am
Q&A
10:00-10:15 am
Break
10:15-10:30 am
Cervical cancer staging: Clinical Implications
10:30-11:15 am
Difficult glandular and miscelanous cervical lesions
11:15 am-12:15 pm
Q&A
12:15-12:30 pm
Lunch
12:30-1:15 pm
Contemporary diagnosis of endometrial cancer
1:15-2:00 pm
Mimickers of endometrial neoplasia in biopsy
2:00-3:00 pm
Q&A
3:00-3:15 pm
Break
3:15-3:30 pm
How to interpret molecular testing results in gynecologic cancer
3:30-4:15 pm
Biomarker testing in gynecologic malignancies
4:15-5:00 pm
Q&A
5:00-5:15 pm
Tuesday, April 13, 2027
Risk stratification in uterine smooth muscle neoplasia
8:00-8:45 am
Unusual variants of uterine smooth muscle neoplasia
8:45-9:45 am
Q&A
9:45-10:00 am
Break
10:00-10:15 am
Endometrial stromal and miscellaneous mesenchymal neoplasms
10:15-11:00 am
Vulvo-vaginal mesenchymal lesions
11:00 am-12:00 pm
Q&A
12:00-12:15 pm
Lunch
12:15-1:00 pm
Histologic typing and grading of tubo-ovarian carcinoma
1:00-1:45 pm
Challenges in peritoneal pathology
1:45-2:45 pm
Q&A
2:45-3:00 pm
Break
3:00-3:15 pm
Germ cell and miscelaneous ovarian tumors
3:15-4:00 pm
Sex cord stromal neoplasms of the ovary
4:00-5:00 pm
Q&A
5:00-5:15 pm
Wednesday, April 14, 2027
Placenta accreta spectrum and related disorders
8:00-8:30 am
Trophoblastic gestational neoplasia in biopsy material
8:30-9:30 am
Q&A
9:30-9:45 am
Break
9:45-10:00 am
Vascular disorders of the placenta
10:00-11:00 am
Acute inflammatory lesions of the placenta
11:00-11:30 am
Q&A
11:30-11:45 am
Lunch
11:45 am-12:30 pm
Miscellaneous placental lesions
12:30-1:00 pm
Chronic inflammatory lesions of the placenta
1:00-1:45 pm
Q&A
1:45-2:00 pm
Break
2:00-2:15 pm
Placental correlates of fetal intrauterine stress
2:15-2:45 pm
Challenging gynecologic & obstetric pathology consultation cases (presentations by MGB GYN pathology fellows)
2:45-4:15 pm
Faculty
Harvard Medical School Continuing Education attracts the best and brightest faculty from all around the world. As a student in this course, you’ll have access to outstanding course directors and faculty.
Course Directors
Carlos Parra-Herran
MD | Course Director
- Director, Women's and Perinatal Pathology Fellowship Program, Mass General Brigham
- Associate Professor of Pathology, Harvard Medical School
Gulisa Turashvili
MD, PhD | Course Director
- Director, Gynecologic Pathology Service, Mass General Brigham
- Associate Professor of Pathology, Harvard Medical School
Erin Alston, MD
Pathologist, Mass General Brigham
Instructor in Pathology, Harvard Medical School
John Chambers, BS
Senior Project Coordinator, Department of Pathology, Mass General Brigham
Benjamin Coiner, MD
Women's and Perinatal Pathology Fellow, Brigham and Women's Hospital
Katelyn Dannheim, MD
Pathologist, Mass General Brigham
Assistant Professor of Pathology, Harvard Medical School
Kyle Devins, MD
Pathologist, Mass General Brigham
Assistant Professor of Pathology, Harvard Medical School
Emily Hatheway-Marshall, MD
Women's and Perinatal Pathology Fellow, Brigham and Women's Hospital
Michelle Hirsch, MD, PhD
Pathologist, Mass General Brigham
Professor of Pathology, Harvard Medical School
Anjelica Hodgson, MD
Pathologist, University Health Network
Assistant Professor of Pathology, University of Toronto
Sarah Johnstone, MD, PhD
Pathologist, Mass General Brigham
Assistant Professor of Pathology, Harvard Medical School
Sarah Khan, MD
Women's and Perinatal Pathology Fellow, Brigham and Women's Hospital
David Kolin, MD, PhD
Pathologist, Mass General Brigham
Associate Professor of Pathology, Harvard Medical School
Andrew Leader, MD, PhD
Women's and Perinatal Pathology Fellow, Brigham and Women's Hospital
Lawrence Lin, MD, PhD
Pathologist, Mass General Brigham
Assistant Professor of Pathology, Harvard Medical School
Zehra Ordulu, MD
Pathologist, Mass General Brigham
Assistant Professor of Pathology, Harvard Medical School
Bradley Quade, MD, PhD
Pathologist, Mass General Brigham
Associate Professor of Pathology, Harvard Medical School
Lauren Ray, MD
Surgical Pathology Fellow, Massachusetts General Hospital
Aarti Sharma, MD
Pathologist, Mass General Brigham
Assistant Professor of Pathology, Harvard Medical School
Negar Taheri, MD
Anatomic Pathology Resident, Mass General Brigham
Dina Zenezan, MD
Surgical Pathology Fellow, Massachusetts General Hospital
Complete Your Registration
Started a registration? Log in to enroll today.
Request Information
Interested in learning more about this program? Sign up for details.
Course Fees
Registration Details
You may register through our secure online environment and will receive an email confirmation upon receipt of your payment. Prices include CME credit, electronic syllabus, and access to some recordings for 90 days after the course. At the end of the registration process, a $10 non-refundable processing fee will be added to your registration.
| Role | Course Fee |
|---|---|
| Physician (MD/DO) | $700 |
| Resident / Fellow | $200 |
| Allied Health Professional / Other | $700 |
Physicians and residents/fellows from low- and middle-income countries may be eligible for a discounted registration rate. Please email learn@hms.harvard.edu to inquire about eligibility and receive the discount.
Accreditation
The Harvard Medical School designates this live activity for a maximum of 22.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For the purpose of recertification, the National Commission on Certification of Physician Assistants, the American Academy of Nurse Practitioners Certification Board and the American Nurses Credentialing Center accept AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME. We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.
The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification. We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.
The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.
The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialists (UEMS). Additional information regarding this agreement may be found on the Union of European Medical Specialists website.